U. Mythily, S. Shyama, S. Subramaniam
U. Mythily1*, S. Shyama2, S. Subramaniam3
1Ph.D Research Scholar, Department of Biochemistry, Regenix Super Speciality Laboratories Pvt Ltd, Choolaimedu, Chennai – 600094.
2Consultant, Lab Services, Apollo Hospitals, Chennai.
3Lab Director, Department of Biochemistry, Regenix Super Speciality Laboratories Pvt Ltd, Choolaimedu, Chennai – 600094.
Volume - 16,
Issue - 2,
Year - 2023
The objective of the present work is to analyze the physiological and histopathological changes observed due to the effect of Ethyl caffeate, a polyphenol compound present in Solanum Nigrum fruits on CCl4 induced liver injury in male albino wistar rats. Thirty rats were used (5 groups, 6 animals per group). Group I is normal control given carboxymethyl cellulose (CMC), Group II is induction control given Carbon tetrachloride (CCl4), Group III (Standard control, Silymarin + CCl4), Group IV (Ethyl caffeate + CCl4) and Group V (Ethyl caffeate alone). At the end of 6 weeks, rats were sacrificed, physiological parameters (body weight, liver weight) were measured and histopathological observation of liver tissues was performed. From the physiological parameter results, body weight of group IV rats were increased (p< 0.05) compared to group II. Enlargement of liver (hepatomegaly) is caused by CCl4 injury in group II (liver weight is increased), while the liver weight was reduced to near normal by ethyl caffeate treatment in group IV. Histolpathological analysis of Ethyl caffeate treated rats (group IV) showed less necrosis with mild periportal inflammation compared to group II rats. The findings of this work suggest that ethyl caffeate possess protective effect against liver injury against CCl4 based on the analysis of physiological and histopathological studies.
Cite this article:
U. Mythily, S. Shyama, S. Subramaniam. Physiological and Histopathological Evaluation of the effect of Ethyl Caffeate on Carbon Tetrachloride (CCl4) Induced Liver Injury in Rats. Research Journal of Pharmacy and Technology 2023; 16(2):519-3. doi: 10.52711/0974-360X.2023.00088
U. Mythily, S. Shyama, S. Subramaniam. Physiological and Histopathological Evaluation of the effect of Ethyl Caffeate on Carbon Tetrachloride (CCl4) Induced Liver Injury in Rats. Research Journal of Pharmacy and Technology 2023; 16(2):519-3. doi: 10.52711/0974-360X.2023.00088 Available on: https://rjptonline.org/AbstractView.aspx?PID=2023-16-2-7
1. Murtadha JH. Hashim I. Razzaq A. Study of liver function and lipid profile changes in Iraqi cirrhotic patients. Research Journal of Pharmacy and Technology. 2020; 13(4): 1837-40. doi.org/10.5958/0974-360X.2020.00331.5
2. Chigozie IJ. Chidinma IC. Hepatoprotective Effect of an Aqueous Extract of the Rhizomes of Sansevieria senegambica Baker against Carbon Tetrachloride Induced Liver Injury. Asian Journal of Research in Chemistry. 2011; 4(12): 1854-60
3. Rehm J. Samokhvalov AV. Shield KD. Global burden of alcoholic liver diseases. Journal of Hepatology. 2013; 59(1): 160-8. doi.org/10.1016/j.jhep.2013.03.007
4. Sivakrishnan S. Liver diseases - an overview. World Journal of Pharmacy and Pharmceutical science. 2019; 8(1): 1385-95. doi.org/10.20959/wjpps20191-13036
5. Asrani SK. Devarbhavi H. Eaton J. Kamath PS. Burden of liver diseases in the world. Journal of Hepatology. 2019; 70(1):151-171. doi.org/10.1016/j.jhep.2018.09.014
6. Riley TR 3rd. Bhatti AM. Preventive Strategies in Chronic Liver Disease: Part I. Alcohol, Vaccines, Toxic Medications and Supplements, Diet and Exercise. American Family Physician. 2001; 64(9): 1555-60.
7. Grewal AS. Thapa K. Bansal A. Deepshikha. Sharma N. Singh S. Therapeutic role of nuclear factor erythroid-2 related factor (Nrf2) in liver disorders. Research Journal of Pharmacy and Technology. 2020; 13(8): 3952-3956. doi.org/10.5958/0974-360X.2020.00699.X
8. Duval F. Moreno-Cuevas JE. González-Garza MT. Maldonado-Bernal C. Cruz-Vega DE. Liver fibrosis and mechanisms of the protective action of medicinal plants targeting inflammation and the immune response. International Journal of Inflammation. 2015; 2015:943497. doi.org/10.1155/2015/943497
9. Srivastava R. Srivastava P. Hepatotoxicity and the Role of Some Herbal Hepatoprotective Plants in Present Scenario. International Journal of Digestive Diseases. 2018; 3(2):1-4. doi.org/10.4172/2472-1891.100034
10. Wang H. Hou W. Perera A. Bettler C. Beach JR. Ding X. Li J. Denning MF. Dhanarajan A. Cotler SJ. Joyce C. Yin J. Ahmed F. Roberts LR. Qiu W. Targeting EphA2 suppresses hepatocellular carcinoma initiation and progression by dual inhibition of JAK1/STAT3 and AKT signalling. Cell reports. 2021; 34(8):108765. doi.org/10.1016/j.celrep.2021.108765
11. Wang H. Qiu W. EPHA2, a promising therapeutic target for hepatocellular carcinoma. Molecular and Cellular Oncology. 2021; 8(3):1910009. doi.org/10.1080/237235.2021.1910009
12. Jain R, Sharma A, Gupta S, Sarethy IP, Gabrani R. Solanum nigrum: Current Perspectives on Therapeutic Properties. Alternative Medicine Review. 2011; 16(1):78-85
13. Cai XF. Chin YW. Oh SR. Kwon OK. Ahn KS. Lee HK. Anti-inflammatory Constituents from Solanum nigrum. Bulletin Korean Chemical Society. 2010; 31(1):199-201. doi.org/10.5012/bkcs.2010.31.01.199
14. Ma KF. Yang HY. Chen Z. Qi LY. Enhanced expressions and activations of leukotriene C4 synthesis enzymes in D-galactosamine/lipopolysaccharide-induced rat fulminant hepatic failure model. World Journal of Gastroenterology. 2008; 14(17): 2748–56. doi.org/10.3748/wjg.14.2748
15. Mythily U. Subramaniam S. Shyama S: Molecular docking studies on phytochemicals of Solanum nigrum fruits for its hepatoprotective activity. International Journal of Pharmaceutical Sciences and Resesearch. 2020; 11(8): 3717-24. doi.org/10.13040/IJPSR.0975-8232.11(8).3717-24
16. Aldhafiri FK. Santhanaraj B. Selvam G. Ahamed KSZ. Subbaiya R. Kumaresan S. Ponmurugan P. Hepatoprotective Studies of Methanolic Leaf Extract of Barringtonia acutangula (L) against Carbon Tetrachloride Induced Liver Injury in Wistar Rats. Research Journal of Pharmacy and Technology. 2017; 10(1): 101-107. doi.org/10.5958/0974-360X.2017.00024.5
17. Liedtke C. Luedde T. Sauerbruch T. Scholten D. Streetz K. Tacke F. Tolba R. Trautwein C. Trebicka J. Weiskirchen R. Experimental liver fibrosis research: update on animal models, legal issues and translational aspects. Fibrogenesis & Tissue repair. 2013; 6(1):19. doi.org/10.1186/1755-1536-6-19
18. Alson SG. Jansen O. Cieckiewicz E. Rakotoarimanana H. Rafatro H. Degotte G. Francotte P. Frederich M. In vitro and in vivo antimalarial activity of caffeic acid and some of its derivatives. Journal of Pharmacy and Pharmacology. 2018; 70(10):1349-56. doi.org/10.1111/jphp.12982
19. Tahmasebi M. Sadeghi H. Nazem H. Kokhdan EP. Omidifar N. Hepatoprotective effects of Berberis vulgaris leaf extract on carbon tetrachloride-induced hepatotoxicity in rats. Journal of Education and Health Promotion. 2018; 7:147. doi.org/10.4103/jehp.jehp_48_17.
20. Bhavani R. Geetha G. Santhoshkumar J. Rajeshkumar S. Evaluation of Antibacterial action and Hepatoprotective efficiency of Solanum nigrum leaves extract on acetaminophen induced hepatotoxicity. Research Journal of Pharmacy and Technology. 2015; 8(7): 893-900. doi.org/10.5958/0974-360X.2015.00145.6
21. Mir A. Anjum F. Riaz N. Iqbal H. Wahedi HM. Khattak JZK. Khan MA. Malik SA. Carbon Tetrachloride (CCL4) - induced hepatotoxicity in rats: Curative role of Solanum Nigrum. Journal of Medicinal Plants Research. 2010; 4(23): 2525-32. doi.org/10.5897/JMPR10.482
22. Raju K, Anbuganapathi G, Gokulakrishnan V, Rajkapoor B, Jayakar B, Manian S. Effect of Dried Fruits of Solanum nigrum Linn against CCl4-Induced Hepatic Damage in Rats. Biological and Pharmacological Bulletin. 2003, 26(11):1618-19. doi.org/10.1248/bpb.26.1618